Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49,760 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The landscape of cancer research and cancer care in China.
Lu Z, Chen Y, Liu D, Jiao X, Liu C, Wang Y, Zhang Z, Jia K, Gong J, Yang Z, Shen L. Lu Z, et al. Among authors: yang z. Nat Med. 2023 Dec;29(12):3022-3032. doi: 10.1038/s41591-023-02655-3. Epub 2023 Dec 12. Nat Med. 2023. PMID: 38087112 Review.
Anticancer drug R&D landscape in China.
Zhao S, Zhao H, Lv C, Gong J, Zhang J, Fang W, Li J, Hu X, Ba Y, Xu B, Zhang Y, Fan Y, Li K, Chen X, Yang Z, Shen L, Zhang L. Zhao S, et al. Among authors: yang z. J Hematol Oncol. 2020 May 13;13(1):51. doi: 10.1186/s13045-020-00877-3. J Hematol Oncol. 2020. PMID: 32404176 Free PMC article. No abstract available.
Time to raise the bar: Transition rate of phase 1 programs on anticancer drugs.
Zhao S, Wang D, Zhao H, Gong J, Zhang J, Fang W, Ma F, Xu B, Li J, Hu X, Ba Y, Chen X, Yang Z, Shen L, Jiang J, Zhang L; Chinese Phase 1 Oncology Trial Consortium. Zhao S, et al. Among authors: yang z. Cancer Cell. 2022 Mar 14;40(3):233-235. doi: 10.1016/j.ccell.2022.01.007. Epub 2022 Feb 24. Cancer Cell. 2022. PMID: 35290782 Free article. No abstract available.
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy.
Zhou M, Chen X, Zhang H, Xia L, Tong X, Zou L, Hao R, Pan J, Zhao X, Chen D, Song Y, Qi Y, Tang L, Liu Z, Gao R, Shi Y, Yang Z. Zhou M, et al. Among authors: yang z. Cancer Commun (Lond). 2019 Jun 20;39(1):36. doi: 10.1186/s40880-019-0383-7. Cancer Commun (Lond). 2019. PMID: 31221221 Free PMC article. Review.
49,760 results
You have reached the last available page of results. Please see the User Guide for more information.